Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Bin Sayeed MS
2020 Jul 9
intraperitoneal injections) lowers brain Aβ 40 by 37% in guinea pigs
Guanidine hydrochloride at low concentrations refolds acid-unfolded apomyoglobin and cytochrome c
6-dihydropyridin-3-yl)phenyl]-1
Avatrombopag Catalog No.:M11396-10 Bin Sayeed MSAvatrombopag, also known as AKR 501, YM477, AS 1670542 or E5501, is a novel orally active thrombopoietin (TPO) receptor agonist. AKR 501 specifically targeted the TPO receptor and stimulated megakaryocytopoiesis throughout the development and maturation of megakaryocytes just as rhTPO did. AKR 501 may be useful in the treatment of patients with thrombocytopenia. Avatrombopag was first approved in 2018. Product information CAS Number: 570406 98 3
US$ 26.00
US$ 24.00
US$ 36.00
US$ 26.00